Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 317507, 6 pages
http://dx.doi.org/10.1155/2015/317507
Review Article

Sodium-Glucose Linked Transporter-2 Inhibitors in Chronic Kidney Disease

1Department of Internal Medicine, University of Catania, 95100 Catania, Italy
2Department of Nephrology, Presidio Ospedaliero Agrigento, 92100 Agrigento, Italy
3Department of Nephrology, San Bassiano Hospital, 36061 Bassano del Grappa, Italy

Received 24 July 2014; Revised 1 February 2015; Accepted 2 February 2015

Academic Editor: Moses Elisaf

Copyright © 2015 L. Zanoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Nasser Mikhail, “Remogliflozin etabonate: A novel SGLT2 inhibitor for treatment of diabetes mellitus,” Expert Opinion on Investigational Drugs, vol. 24, no. 10, pp. 1381–1387, 2015. View at Publisher · View at Google Scholar
  • Romina Bertinat, Francisco Nualart, and Alejandro J. Yáñez, “SGLT2 Inhibitors: Glucotoxicity and Tumorigenesis Downstream the Renal Proximal Tubule?,” Journal of Cellular Physiology, vol. 231, no. 8, pp. 1635–1637, 2015. View at Publisher · View at Google Scholar
  • Jose Górriz, Javier Nieto, Juan Navarro-González, Pablo Molina, Alberto Martínez-Castelao, and Luis Pallardó, “Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?,” Journal of Clinical Medicine, vol. 4, no. 10, pp. 1866–1889, 2015. View at Publisher · View at Google Scholar
  • Prachi Gupta, Manju Bala, Sanjeev Gupta, Anita Dua, Rajesh Dabur, Elisha Injeti, and Ashwani Mittal, “Efficacy and Risk profile of Anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action,” Pharmacological Research, 2016. View at Publisher · View at Google Scholar
  • Sanjay Kalra, Vikram Singh, and Dinesh Nagrale, “Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review,” Advances in Therapy, 2016. View at Publisher · View at Google Scholar
  • Auryan Szalat, Amichai Perlman, Mordechai Muszkat, Mogher Khamaisi, Zaid Abassi, and Samuel N. Heyman, “Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia,” Drug Safety, 2017. View at Publisher · View at Google Scholar
  • Tuba M. Ansary, Yoshihide Fujisawa, Asadur Rahman, Daisuke Nakano, Hirofumi Hitomi, Hideki Kobara, Tsutomu Masaki, Jens M. Titze, Kento Kitada, and Akira Nishiyama, “Responses of renal hemodynamics and tubular functions to acute sodium–glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Leszek Szablewski, “Distribution of glucose transporters in renal diseases,” Journal of Biomedical Science, vol. 24, no. 1, 2017. View at Publisher · View at Google Scholar
  • Daiji Kawanami, Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Tomoyo Akamine, Tamotsu Yokota, Kazunori Sango, and Kazunori Utsunomiya, “SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy,” International Journal of Molecular Sciences, vol. 18, no. 6, pp. 1083, 2017. View at Publisher · View at Google Scholar
  • Joseph A. Messana, Stanley S. Schwartz, and Raymond R. Townsend, “An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes,” Vascular Health and Risk Management, vol. 13, pp. 43–54, 2017. View at Publisher · View at Google Scholar
  • Krit Jaikumkao, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Siriporn C. Chattipakorn, Nipon Chattipakorn, and Anusorn Lungkaphin, “The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes,” Biomedicine & Pharmacotherapy, vol. 94, pp. 176–187, 2017. View at Publisher · View at Google Scholar
  • Lin Zhang, Mei Zhang, Qingguo Lv, and Nanwei Tong, “Efficacy and Safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A Systematic Review and Meta-Analysis,” Diabetes Research and Clinical Practice, 2018. View at Publisher · View at Google Scholar
  • Sonia Sifuentes-Franco, Diego Enrique Padilla-Tejeda, Sandra Carrillo-Ibarra, and Alejandra Guillermina Miranda-Díaz, “Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy,” International Journal of Endocrinology, vol. 2018, pp. 1–13, 2018. View at Publisher · View at Google Scholar